Make an appointment

Chronic Obstructive Pulmonary Disease (COPD)


Swiss Medica Clinic has 20 years of successful clinical experience in a field of restoration, regeneration, revitalization of the organism and in treating, preventing various chronic and age related diseases. We work with modern technologies (stem cells therapy, RNA-based medications, cellular active factors and etc) endlessly improving our skills, knowledge and approaches in this sphere.

We have a great success rate in treating Chronic Obstructive Pulmonary Diseases (COPD). Activated Mesenchymal Stromal Fraction Cells Therapy clinically proved it's effectiveness in helping patients with COPD.

100% of our patients with COPD have improvements. Their therapeutical success may reveals not only in breathing, sleeping and general health condition but also in mood, energy, vigor, stamina, desire and ability which increase during several months after discharge from the Clinic. Approximately 70% of treated patients reduce medication dosages and some of them even refuse them.

All our COPD treatment programs are individually tailored and based on patient's needs and diagnosed condition.

Why the SwissMedica?

  • Effectively prevention of acute and chronic diseases.
  • Up-to-date equipment and technologies (RNA-based medications, cellular active factors, RNA-based medications).
  • Use of mesenchymal tissue cells excludes any rejection.
  • Absolute safety.
  • Our technology activates the reserves of the human body: it heals itself from its own hidden reserves.
  • Life source even for the "hopeless" patients, who share their histories.
  • 20 years of successful clinical experience in regeneration and restoration of the organism.
  • Everyday improvement of skills.
  • Use of patient's own mesenchymal stem cells.

We offer 3 and 12 days treatment programs (or individually tailored program). Furthermore, the patients are under the follow-up for 6 months after the end of the therapy. It usually takes about 2–4 month to feel the result. Treatment is arranged in Luсerne (Switzerland), Belgrade (Serbia) and Moscow (Russia).

Contact us if you are interested in.